ARCR_Pred Cohort Study


Our group has been initiating and supporting the Swiss study ARCR_Pred, since its funding in 2020. It has been the result of a collaboration between 18 Swiss Orthopedic centers and 1 in Germany.

Discover the sites and partners View Publications

ARCR_Pred Cohort Study

Latest News

Sep 25, 2023
2. Best Practice in Healthcare

Prof. Laurent Audigé presented the ARCR_Pred study in the context the 2nd Best Practice in Healthcare congress, held at the Schulthess Klinik, Zürich.

Jun 22, 2023
Participant Community Newsletter #2 (June 2023)

A project update dedicated to ARCR_Pred study patients.

Jun 21, 2023
Newsletter #6 (June 2023)

A project update about the end of the 2 year follow-up and the validation of the adverse events classification.

Jan 25, 2023
BeeMed - Learn from the Masters in Shoulder

Prof. Laurent Audigé and Prof. Andreas Müller disscussed the issues for the successful implementation of the ARCR_Pred Cohort Study

Dec 31, 2022
Newsletter #5 (December 2022)

A project update about the end of the 1 year follow-up, the status of the 2 years follow-up, the MRI sub-project, and the status of analysis and reporting.

See all

Fundings

Swiss National Science Foundation

The Swiss National Science Foundation is the main funder for the ARCR_Pred study.

Swiss National Science Foundation
Swiss Orthopaedics

Swiss Orthopaedics has been one of the main funder for the ARCR_Pred study.

Swiss Orthopaedics
SUVA grant

The SUVA grant was obtained in the context of our sub-project ARCR_Pred_MRI.

SUVA grant

About us


Our research activities

We are currently focused on the achievement of our study ARCR_Pred, which objectives are multiple: development and validation of clinical prediction models in the context of Orthopedic Surgery and the development and validation of adverse events classification.

Our research interests

Including various profiles, such as orthopedic surgeons, physiotherapists, study nurses, clinical epidemiologists or biostatisticians, our research interests are diverse.

We are all interested in improving patients outcomes and their overall healthcare experience.